Dyne Therapeutics, Inc.
DYN • NASDAQ
Dyne Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John G. Cox, with a market cap of $2.8B.
CEOJohn G. Cox
Next Earnings
Upcoming earnings announcement for Dyne Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.77
Earnings History
Past 12 earnings reports for Dyne Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$0.76Est: -$0.75 | -1.3% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.76Est: -$0.83 | +8.4% | - | — | 10-Q |
| Jul 28, 2025 | Q2 2025 | -$0.97Est: -$0.96 | -1.0% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.05Est: -$0.84 | -25.0% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.88Est: -$0.75 | -17.3% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.96Est: -$0.71 | -35.2% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.70Est: -$0.72 | +2.8% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.81Est: -$0.80 | -1.3% | - | — | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$1.09Est: -$0.92 | -18.5% | - | — | 10-K |
| Oct 30, 2023 | Q3 2023 | -$0.99Est: -$0.83 | -19.3% | - | — | 10-Q |
| Aug 3, 2023 | Q2 2023 | -$1.08Est: -$0.81 | -33.3% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.78Est: -$0.77 | -1.3% | - | — | — |